_id
6911c01bccc777a4e85d6360
Ticker
GRTX
Name
Galera Therapeutics Inc
Exchange
OTCQB
Address
101 Lindenwood Drive, Malvern, PA, United States, 19355
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.galeratx.com
Description
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy that is in Phase 2a clinical trial. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.
Last Close
0.024
Volume
1000
Current Price
0.024
Change
0
Last Updated
2025-11-30T19:35:55.814Z
Image
data:image/webp;base64,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
Ipo Date
2019-11-07T00:00:00.000Z
Market Cap
1660172
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
0.5
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1436000
Operating Income
-1436000
Interest Expense
-
Pretax Income
-1388000
Net Income
-1388000
Eps
-0.01839326848778577
Dividends Per Share
-
Shares Outstanding
75462390
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
4473000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
4901000
Property Plant Equipment
-
Total Assets
5002000
Payables
434000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
154224000
Equity
-149222000
Depreciation
0
Change In Working Capital
540000
Cash From Operations
-757000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-757000
PE
-
PB
-0.012136932623875836
ROE
0.930157751537977
ROA
-27.74890043982407
FCF
-757000
Fcf Percent
-
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
1
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1436000
Quarters > 0 > income Statement > operating Income
-1436000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1388000
Quarters > 0 > income Statement > net Income
-1388000
Quarters > 0 > income Statement > eps
-0.01839326848778577
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
75462390
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
4473000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4901000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
5002000
Quarters > 0 > balance Sheet > payables
434000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
154224000
Quarters > 0 > balance Sheet > equity
-149222000
Quarters > 0 > cash Flow > net Income
-1388000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
540000
Quarters > 0 > cash Flow > cash From Operations
-757000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-757000
Quarters > 0 > ratios > PE
-0.01839326848778577
Quarters > 0 > ratios > PB
-0.012136932623875836
Quarters > 0 > ratios > ROE
0.930157751537977
Quarters > 0 > ratios > ROA
-27.74890043982407
Quarters > 0 > ratios > FCF
-757000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
1135000
Quarters > 1 > income Statement > operating Income
-1135000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1075000
Quarters > 1 > income Statement > net Income
-1075000
Quarters > 1 > income Statement > eps
-0.014245506933983935
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
75462390
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
5230000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5947000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
6048000
Quarters > 1 > balance Sheet > payables
202000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
153993000
Quarters > 1 > balance Sheet > equity
-147945000
Quarters > 1 > cash Flow > net Income
-1075000
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
-471000
Quarters > 1 > cash Flow > cash From Operations
-1456000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-1456000
Quarters > 1 > ratios > PE
-0.014245506933983935
Quarters > 1 > ratios > PB
-0.012241693602352227
Quarters > 1 > ratios > ROE
0.7266213795667309
Quarters > 1 > ratios > ROA
-17.7744708994709
Quarters > 1 > ratios > FCF
-1456000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1963000
Quarters > 2 > income Statement > operating Income
-1963000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1592000
Quarters > 2 > income Statement > net Income
-1592000
Quarters > 2 > income Statement > eps
-0.01616187375404085
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
98503430
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1963000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
371000
Quarters > 2 > balance Sheet > cash
6686000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
7560000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
7661000
Quarters > 2 > balance Sheet > payables
744000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
152024000
Quarters > 2 > balance Sheet > equity
-144363000
Quarters > 2 > cash Flow > net Income
-1592000
Quarters > 2 > cash Flow > depreciation
0
Quarters > 2 > cash Flow > change In Working Capital
-489000
Quarters > 2 > cash Flow > cash From Operations
-2238000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
635000
Quarters > 2 > cash Flow > net Change In Cash
-1603000
Quarters > 2 > ratios > PE
-0.01616187375404085
Quarters > 2 > ratios > PB
-0.016375957274370856
Quarters > 2 > ratios > ROE
1.1027756419581194
Quarters > 2 > ratios > ROA
-20.78057694817909
Quarters > 2 > ratios > FCF
-2238000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
3834000
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1776000
Quarters > 3 > income Statement > operating Income
-5466000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-4931000
Quarters > 3 > income Statement > net Income
-4931000
Quarters > 3 > income Statement > eps
-0.09025644930469495
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
54633215
Quarters > 3 > income Statement > income Tax Expense
34276
Quarters > 3 > income Statement > EBITDA
-5061724
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
535000
Quarters > 3 > balance Sheet > cash
8289000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
635000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
10001000
Quarters > 3 > balance Sheet > property Plant Equipment
0
Quarters > 3 > balance Sheet > total Assets
10101000
Quarters > 3 > balance Sheet > payables
1275000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
153770000
Quarters > 3 > balance Sheet > equity
-143669000
Quarters > 3 > cash Flow > net Income
-4931000
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
-1195000
Quarters > 3 > cash Flow > cash From Operations
-2339000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2223000
Quarters > 3 > cash Flow > net Change In Cash
-166000
Quarters > 3 > ratios > PE
-0.09025644930469495
Quarters > 3 > ratios > PB
-0.009126514140141576
Quarters > 3 > ratios > ROE
3.4321948367427906
Quarters > 3 > ratios > ROA
-48.816948816948816
Quarters > 3 > ratios > FCF
-2339000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3843000
Annuals > 0 > income Statement > gross Profit
-3843000
Annuals > 0 > income Statement > operating Expenses
14153000
Annuals > 0 > income Statement > operating Income
-20160000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-19160000
Annuals > 0 > income Statement > net Income
-18957000
Annuals > 0 > income Statement > eps
-0.3469867186106474
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
54633215
Annuals > 0 > income Statement > income Tax Expense
-203000
Annuals > 0 > income Statement > EBITDA
-20160000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1000000
Annuals > 0 > balance Sheet > cash
8289000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
635000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10001000
Annuals > 0 > balance Sheet > property Plant Equipment
0
Annuals > 0 > balance Sheet > total Assets
10101000
Annuals > 0 > balance Sheet > payables
1275000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
153770000
Annuals > 0 > balance Sheet > equity
-143669000
Annuals > 0 > cash Flow > net Income
-18957000
Annuals > 0 > cash Flow > depreciation
20000
Annuals > 0 > cash Flow > change In Working Capital
-2128000
Annuals > 0 > cash Flow > cash From Operations
-12145000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
2223000
Annuals > 0 > cash Flow > net Change In Cash
-9968000
Annuals > 0 > ratios > PE
-0.3469867186106474
Annuals > 0 > ratios > PB
-0.00802372701487447
Annuals > 0 > ratios > ROE
13.194913307672499
Annuals > 0 > ratios > ROA
-187.67448767448766
Annuals > 0 > ratios > FCF
-12145000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
259000
Annuals > 1 > income Statement > gross Profit
-259000
Annuals > 1 > income Statement > operating Expenses
46692000
Annuals > 1 > income Statement > operating Income
-46951000
Annuals > 1 > income Statement > interest Expense
11414000
Annuals > 1 > income Statement > pretax Income
-59082000
Annuals > 1 > income Statement > net Income
-59082000
Annuals > 1 > income Statement > eps
-1.3262166009222505
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
44549284
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-46692000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-12131000
Annuals > 1 > balance Sheet > cash
18257000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
21629000
Annuals > 1 > balance Sheet > property Plant Equipment
1283000
Annuals > 1 > balance Sheet > total Assets
26141000
Annuals > 1 > balance Sheet > payables
1375000
Annuals > 1 > balance Sheet > short Term Debt
133000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
157326000
Annuals > 1 > balance Sheet > equity
-131185000
Annuals > 1 > cash Flow > net Income
-59082000
Annuals > 1 > cash Flow > depreciation
259000
Annuals > 1 > cash Flow > change In Working Capital
-2927000
Annuals > 1 > cash Flow > cash From Operations
-44848000
Annuals > 1 > cash Flow > capital Expenditures
59000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
31496000
Annuals > 1 > cash Flow > net Change In Cash
13941000
Annuals > 1 > ratios > PE
-1.3262166009222505
Annuals > 1 > ratios > PB
-0.007165376318938903
Annuals > 1 > ratios > ROE
45.03716126081488
Annuals > 1 > ratios > ROA
-226.0127768639302
Annuals > 1 > ratios > FCF
-44907000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
114000
Annuals > 2 > income Statement > gross Profit
-114000
Annuals > 2 > income Statement > operating Expenses
51226000
Annuals > 2 > income Statement > operating Income
-51226000
Annuals > 2 > income Statement > interest Expense
11571000
Annuals > 2 > income Statement > pretax Income
-62292000
Annuals > 2 > income Statement > net Income
-62222000
Annuals > 2 > income Statement > eps
-2.2971451929259357
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
27086664
Annuals > 2 > income Statement > income Tax Expense
-70000
Annuals > 2 > income Statement > EBITDA
-51112000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-11066000
Annuals > 2 > balance Sheet > cash
4266000
Annuals > 2 > balance Sheet > short Term Investments
27331000
Annuals > 2 > balance Sheet > receivables
3242000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
38535000
Annuals > 2 > balance Sheet > property Plant Equipment
481000
Annuals > 2 > balance Sheet > total Assets
44036000
Annuals > 2 > balance Sheet > payables
3581000
Annuals > 2 > balance Sheet > short Term Debt
88000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
153217000
Annuals > 2 > balance Sheet > equity
-109181000
Annuals > 2 > cash Flow > net Income
-62222000
Annuals > 2 > cash Flow > depreciation
114000
Annuals > 2 > cash Flow > change In Working Capital
17000
Annuals > 2 > cash Flow > cash From Operations
-43426000
Annuals > 2 > cash Flow > capital Expenditures
25000
Annuals > 2 > cash Flow > cash From Investing
23994000
Annuals > 2 > cash Flow > cash From Financing
3889000
Annuals > 2 > cash Flow > net Change In Cash
-15543000
Annuals > 2 > ratios > PE
-2.2971451929259357
Annuals > 2 > ratios > PB
-0.0052346892811020234
Annuals > 2 > ratios > ROE
56.98976928220112
Annuals > 2 > ratios > ROA
-141.29802888545734
Annuals > 2 > ratios > FCF
-43451000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
778000
Annuals > 3 > income Statement > gross Profit
-778000
Annuals > 3 > income Statement > operating Expenses
73368000
Annuals > 3 > income Statement > operating Income
-73368000
Annuals > 3 > income Statement > interest Expense
7194000
Annuals > 3 > income Statement > pretax Income
-80534000
Annuals > 3 > income Statement > net Income
-87728000
Annuals > 3 > income Statement > eps
-3.40170002797267
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25789458
Annuals > 3 > income Statement > income Tax Expense
7194000
Annuals > 3 > income Statement > EBITDA
-72558000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-7166000
Annuals > 3 > balance Sheet > cash
19859000
Annuals > 3 > balance Sheet > short Term Investments
51358000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
77392000
Annuals > 3 > balance Sheet > property Plant Equipment
823000
Annuals > 3 > balance Sheet > total Assets
83311000
Annuals > 3 > balance Sheet > payables
5044000
Annuals > 3 > balance Sheet > short Term Debt
516000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
141315000
Annuals > 3 > balance Sheet > equity
-58004000
Annuals > 3 > cash Flow > net Income
-80534000
Annuals > 3 > cash Flow > depreciation
778000
Annuals > 3 > cash Flow > change In Working Capital
-2627000
Annuals > 3 > cash Flow > cash From Operations
-67958000
Annuals > 3 > cash Flow > capital Expenditures
283000
Annuals > 3 > cash Flow > cash From Investing
5238000
Annuals > 3 > cash Flow > cash From Financing
66707000
Annuals > 3 > cash Flow > net Change In Cash
3987000
Annuals > 3 > ratios > PE
-3.40170002797267
Annuals > 3 > ratios > PB
-0.009381379970346873
Annuals > 3 > ratios > ROE
151.24474174194884
Annuals > 3 > ratios > ROA
-105.30182088799798
Annuals > 3 > ratios > FCF
-68241000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.01839326848778577
Valuation > metrics > PB
-0.012136932623875836
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
0.930157751537977
Profitability > metrics > ROA
-28.320750867169963
Profitability > final Score
17
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.2926267281106
Liquidity > metrics > Quick Ratio
11.2926267281106
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
16
Prev Profitabilities > 1
17
Prev Profitabilities > 2
22
Prev Risks > 0
50
Prev Risks > 1
9
Prev Risks > 2
-137
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:44:55.952Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-27
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.01
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.01
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.01
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.01
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0891
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
-0.3
Earnings History > 3 > eps Difference
0.3
Earnings History > 3 > surprise Percent
100
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-29
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1026
Earnings History > 4 > eps Estimate
-0.29
Earnings History > 4 > eps Difference
0.1874
Earnings History > 4 > surprise Percent
64.6207
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.07
Earnings History > 5 > eps Estimate
0.83
Earnings History > 5 > eps Difference
-0.9
Earnings History > 5 > surprise Percent
-108.4337
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0805
Earnings History > 6 > eps Estimate
-0.2944
Earnings History > 6 > eps Difference
0.2139
Earnings History > 6 > surprise Percent
72.6563
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-28
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1027
Earnings History > 7 > eps Estimate
-0.35
Earnings History > 7 > eps Difference
0.2473
Earnings History > 7 > surprise Percent
70.6571
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.28
Earnings History > 8 > eps Estimate
-0.4
Earnings History > 8 > eps Difference
0.12
Earnings History > 8 > surprise Percent
30
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.48
Earnings History > 9 > eps Estimate
-0.38
Earnings History > 9 > eps Difference
-0.1
Earnings History > 9 > surprise Percent
-26.3158
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.5
Earnings History > 10 > eps Estimate
-0.38
Earnings History > 10 > eps Difference
-0.12
Earnings History > 10 > surprise Percent
-31.5789
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-08
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.58
Earnings History > 11 > eps Estimate
-0.54
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-7.4074
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.6
Earnings History > 12 > eps Estimate
-0.52
Earnings History > 12 > eps Difference
-0.08
Earnings History > 12 > surprise Percent
-15.3846
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-09
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.54
Earnings History > 13 > eps Estimate
-0.53
Earnings History > 13 > eps Difference
-0.01
Earnings History > 13 > surprise Percent
-1.8868
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.58
Earnings History > 14 > eps Estimate
-0.57
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-1.7544
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-10
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.64
Earnings History > 15 > eps Estimate
-0.75
Earnings History > 15 > eps Difference
0.11
Earnings History > 15 > surprise Percent
14.6667
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.86
Earnings History > 16 > eps Estimate
-0.77
Earnings History > 16 > eps Difference
-0.09
Earnings History > 16 > surprise Percent
-11.6883
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-10
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.88
Earnings History > 17 > eps Estimate
-0.83
Earnings History > 17 > eps Difference
-0.05
Earnings History > 17 > surprise Percent
-6.0241
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-11
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.75
Earnings History > 18 > eps Estimate
-0.83
Earnings History > 18 > eps Difference
0.08
Earnings History > 18 > surprise Percent
9.6386
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.8
Earnings History > 19 > eps Estimate
-0.71
Earnings History > 19 > eps Difference
-0.09
Earnings History > 19 > surprise Percent
-12.6761
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.69
Earnings History > 20 > eps Estimate
-0.77
Earnings History > 20 > eps Difference
0.08
Earnings History > 20 > surprise Percent
10.3896
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.75
Earnings History > 21 > eps Estimate
-0.76
Earnings History > 21 > eps Difference
0.01
Earnings History > 21 > surprise Percent
1.3158
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-12
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.74
Earnings History > 22 > eps Estimate
-0.7
Earnings History > 22 > eps Difference
-0.04
Earnings History > 22 > surprise Percent
-5.7143
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-10
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.31
Earnings History > 23 > eps Estimate
-0.55
Earnings History > 23 > eps Difference
-0.76
Earnings History > 23 > surprise Percent
-138.1818
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-12
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.21
Earnings History > 24 > eps Estimate
-0.61
Earnings History > 24 > eps Difference
-0.6
Earnings History > 24 > surprise Percent
-98.3607
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-28
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.45
Earnings History > 25 > eps Estimate
-0.45
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
0
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy that is in Phase 2a clinical trial. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGalera (OTC: GRTX) to sell dismutase mimetics to Biossil; $3.5M upfront, up to $105M - Stock Titan
10/22/2025
Galera (OTC: GRTX) to sell dismutase mimetics to Biossil; $3.5M upfront, up to $105M Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$0.5
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 1.75% of the total shares of Galera Therapeutics Inc
1.
abrdn Healthcare Opportunities(0.5781%)
since
2024/09/30
2.
abrdn Healthcare Investors(0.545%)
since
2024/10/31
3.
abrdn World Healthcare(0.2973%)
since
2024/09/30
4.
abrdn Life Sciences Investors(0.2312%)
since
2024/10/31
5.
XTX Topco Ltd(0.0958%)
since
2024/06/30
6.
State Street Corp(0%)
since
2024/06/30
7.
Susquehanna International Group, LLP(0%)
since
2024/06/30
8.
Atom Investors LP(0%)
since
2024/06/30
9.
Wells Fargo & Co(0%)
since
2024/06/30
10.
Jane Street Group LLC(0%)
since
2024/06/30
11.
Northern Trust Corp(0%)
since
2024/06/30
12.
Millennium Management LLC(0%)
since
2024/06/30
13.
Morgan Stanley - Brokerage Accounts(0%)
since
2024/06/30
14.
U.S. Bancorp(0%)
since
2024/06/30
15.
Good Life Advisors, LLC(0%)
since
2024/06/30
16.
GSA Capital Partners LLP(0%)
since
2024/06/30
17.
Kestra Advisory Services, LLC(0%)
since
2024/06/30
18.
abrdn PLC(0%)
since
2024/06/30
19.
HRT FINANCIAL LLC(0%)
since
2024/06/30
20.
Parallel Advisors, LLC(0%)
since
2024/06/30
21.
Royal Bank of Canada(0%)
since
2024/06/30
22.
Summit Trail Advisors, LLC(0%)
since
2024/06/30
23.
J.W. COLE ADVISORS, INC.(0%)
since
2024/06/30
24.
Level Four Advisory Services, LLC(0%)
since
2024/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.01
EPS Estimate
0
EPS Difference
-0.01
Surprise Percent
null%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.